Your browser doesn't support javascript.
loading
Dorsal column myelopathy after intrathecal chemotherapy for leukemia.
Pinnix, Chelsea C; Chi, Linda; Jabbour, Elias J; Milgrom, Sarah A; Smith, Grace L; Daver, Naval; Garg, Naveen; Cykowski, Matthew D; Fuller, Greg; Cachia, David; Kamiya-Matsuoka, Carlos; Woodman, Karin; Dinardo, Courtney; Jain, Nitin; Kadia, Tapan M; Pemmaraju, Naveen; Ohanian, Maro; Konopleva, Marina; Kantarjian, Hagop M; Dabaja, Bouthaina S.
Afiliación
  • Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chi L; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Milgrom SA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Smith GL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garg N; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cykowski MD; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Fuller G; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Cachia D; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kamiya-Matsuoka C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Woodman K; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dinardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ohanian M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 92(2): 155-160, 2017 Feb.
Article en En | MEDLINE | ID: mdl-27874212
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades de la Médula Espinal / Leucemia / Metotrexato / Antimetabolitos Antineoplásicos Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades de la Médula Espinal / Leucemia / Metotrexato / Antimetabolitos Antineoplásicos Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos